Carregant...
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
It is widely accepted that non-endogenous compounds that target CB(1) and/or CB(2) receptors possess therapeutic potential for the clinical management of an ever growing number of disorders. Just a few of these disorders are already treated with Δ(9)-tetrahydrocannabinol or nabilone, both CB(1)/CB(2...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3013229/ https://ncbi.nlm.nih.gov/pubmed/20166927 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|